Selective Androgen Receptor Modulators (SARMs): A novel approach to androgen therapy for the new millennium

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3459-3462

  Negro Vilar, Andrés ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; FLUOXYMESTERONE; METHYLTESTOSTERONE; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; DRUG FORMULATION; DRUG MECHANISM; FEMALE; HUMAN; HYPOGONADISM; LIVER TOXICITY; MALE; NOTE; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SKIN IRRITATION; STRUCTURE ACTIVITY RELATION;

EID: 0033304913     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.10.6122     Document Type: Note

References (27)

1. Androgens in men-uses and abuses
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
3. Selective estrogen receptor modulators: Clinical spectrum
4. The effect of 2 and 3 years of raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis
5. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as the basis for the cell- and promoter-specific action of these hormones
6. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
7. 8,9 dehydroestrone sulfate in postmenopausal women
8. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: A novel class of nonsteroidal human progesterone receptor agonists
9. Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone
10. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: Intermolecular synergy requires only the PPARgamma hormone-dependent activation function
11. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 vs. PPARγ1 and activation with retinoid X receptor agonists and antagonists
12. Structure and specificity of nuclear receptor-coactivator interactions
13. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1
14. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specifications
15. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor
16. Cloning and characterization of androgen receptor coactivator, ARA54, in human prostate
17. Tip60 is a nuclear hormone receptor coactivator
18. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins
19. New non-steroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone
20. Pharmacology and clinical uses of testosterone
21. Long-term experience with testosterone replacement through scrotal skin
22. A permeation-enhanced non-scrotal testosterone transdermal system for the treatment of male hypogonadism
23. Osteoporosis in men
24. Effect of testosterone treatment on bone mineral density in men over 65 years of age
25. Effects of testosterone replacement with a nongenital, transdermal system, androderm, in human immunodeficiency virus-infected men with low testosterone levels
26. Androgen replacement in women: A commentary
27. Androgens and postmenopausal women